Risk of breast cancer in patients exposed to insulin glargine compared to human NPH insulin.

被引：0

作者：

Boyle, Peter

Wu, Chuntao

Sharma, Kristen

Lin, Stephen

Juhaeri, Juhaeri

机构：

[1] Univ Strathclyde, Inst Global Publ Hlth IPRI, Ecully, France

[2] Sanofi, Bridgewater, NJ USA

[3] Sanofi, Chilly Mazarin, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.e13592

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e13592

引用

页数：1

共 50 条

[1] No Increased Risk of Breast Cancer in Patients Exposed to Insulin Glargine Compared with Human NPH Insulin
Boyle, Peter
Wu, Chuntao
Sharma, Kristen
Lin, Stephen L.
Juhaeri, Juhaeri
DIABETES, 2018, 67
[2] Risk of breast cancer in women initiating insulin glargine compared with insulin detemir Or NPH insulin
Bradley, Marie C.
Chillarige, Yoganand
Lee, Hana
Wu, Xiyuan
Bright, Patricia
Parulekar, Shruti
Wernecke, Michael
Soukup, Mat
Kelman, Jeffrey A.
Graham, David J.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 146 - 146
[3] INSULIN GLARGINE COMPARED TO INSULIN NPH FOR THE MANAGEMENT OF HYPERGLYCEMIA IN CRITICALLY ILL PATIENTS
Anderson, Rebecca
Fox, Marlena
Danesh, Valerie
Gupta, Rakesh
Jones, Timothy
CRITICAL CARE MEDICINE, 2012, 40 (12) : U284 - U285
[4] Glargine Utilization in Russia: A Retrospective Comparative Study To Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Patients Maintained on NPH
Jarek-Martynowa, Iwona
Shamkhalova, Minara
Shestakova, Marina
DIABETES, 2011, 60 : A608 - A608
[5] GLARGINE UTILISATION IN RUSSIA: A PROSPECTIVE STUDY TO EVALUATE PATIENTS SWITCHED FROM NPH INSULIN TO INSULIN GLARGINE COMPARED WITH THOSE MAINTAINED ON NPH
Skudaev, S.
Verbovaya, N.
VALUE IN HEALTH, 2011, 14 (07) : A473 - A473
[6] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
Rosenstock, J
Dailey, G
Massi-Benedetti, M
Fritsche, A
Lin, ZN
Salzman, A
DIABETES CARE, 2005, 28 (04) : 950 - 955
[7] INSULIN GLARGINE COMPARED TO INSULIN NPH FOR THE MANAGEMENT OF HYPERGLYCEMIA IN THE CRITICALLY ILL
Trang, Joseph
Fox, Marlena
Danesh, Valerie
Jones, Timothy
CRITICAL CARE MEDICINE, 2014, 42 (12)
[8] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
DIABETES, 2004, 53 : A291 - A291
[9] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain
Rodríguez, J
Terrés, CR
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A344 - A344
[10] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A345 - A345

← 1 2 3 4 5 →